Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

已收盘 05-09 16:00:00 EDT

3.43

-0.01

-0.29%

盘后3.35

-0.08-2.33%

16:00 EDT

最高3.43	最低3.30	成交量1,937
今开3.36	昨收3.44	日振幅3.78%
总市值1.78亿	流通市值4,820万	总股本5,201万
成交额6,481	换手率0.01%	流通股本1,405万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":3.43,"timestamp":1715284800000,"preClose":3.44,"halted":0,"volume":1937,"hourTrading":{"tag":"盘后","latestPrice":3.35,"preClose":3.43,"latestTime":"16:00 EDT","volume":21,"amount":70.35000000000001,"timestamp":1715284801226},"delay":0,"floatShares":14052264,"shares":52009692,"eps":-2.691362,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.01,"latestTime":"05-09 16:00:00 EDT","open":3.36,"high":3.43,"low":3.3,"amount":6481.022634,"amplitude":0.037791,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.691362,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"listingDate":1594353600000,"adjPreClose":3.44,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":3.35,"preClose":3.43,"latestTime":"16:00 EDT","volume":21,"amount":70.35000000000001,"timestamp":1715284801226},"volumeRatio":0.101321},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2433476451","title":"Inventiva Sa盘中异动 早盘快速上涨7.58%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433476451","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433476451?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:30","pubTimestamp":1715002237,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时30分，Inventiva Sa股票出现波动，股价大幅上涨7.58%。截至发稿，该股报3.55美元/股，成交量1262股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213037861eb2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213037861eb2b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432715634","title":"Inventiva Sa盘中异动 临近收盘大幅拉升5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432715634","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432715634?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:52","pubTimestamp":1714593130,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时52分，Inventiva Sa股票出现波动，股价快速上涨5.54%。截至发稿，该股报3.24美元/股，成交量5972股，换手率0.01%，振幅4.23%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.80%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502035210861ea97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502035210861ea97c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431732696","title":"Inventiva Sa盘中异动 早盘急速下跌5.56%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431732696","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431732696?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:31","pubTimestamp":1714483899,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时31分，Inventiva Sa股票出现异动，股价快速下挫5.56%。截至发稿，该股报3.06美元/股，成交量2000股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.05%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021313987c3f57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021313987c3f57e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428660992","title":"Inventiva Sa盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660992","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660992?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:24","pubTimestamp":1713551052,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时24分，Inventiva Sa股票出现异动，股价急速下挫5.21%。截至发稿，该股报3.27美元/股，成交量5916股，换手率0.01%，振幅3.19%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.02%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420022413861e781d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420022413861e781d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428592453","title":"Inventiva Sa盘中异动 快速上涨6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428592453","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428592453?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:03","pubTimestamp":1713449035,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时03分，Inventiva Sa股票出现异动，股价急速上涨6.83%。截至发稿，该股报3.44美元/股，成交量2700股，换手率0.01%，振幅3.11%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.47%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182203557a53cbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182203557a53cbe7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427886668","title":"Inventiva Sa盘中异动 急速下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427886668","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427886668?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:29","pubTimestamp":1713198578,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时29分，Inventiva Sa股票出现波动，股价快速跳水5.35%。截至发稿，该股报3.36美元/股，成交量5.3776万股，换手率0.10%，振幅5.35%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.33%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160029387a52e028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160029387a52e028&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425957929","title":"加拿大投资银行集团：维持Inventiva(IVA.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2425957929","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425957929?lang=zh_cn&edition=full","pubTime":"2024-04-08 19:55","pubTimestamp":1712577358,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Inventiva(IVA.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040819561087545285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040819561087545285&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":0.0617},{"period":"1month","weight":-0.1088},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0678},{"period":"1year","weight":0.2647},{"period":"ytd","weight":-0.2383}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，致力于开发口服小分子疗法，以治疗非酒精性脂肪性肝炎或NASH，粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道，该发现引擎具有广泛的专有分子库，一个全资研发设施以及一个在开发针对核受体，转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.033773},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02424},{"month":3,"riseRate":0,"avgChangeRate":-0.114231},{"month":4,"riseRate":0,"avgChangeRate":-0.166714},{"month":5,"riseRate":0.75,"avgChangeRate":0.136992},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.116382},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.052},{"month":8,"riseRate":0.25,"avgChangeRate":0.014638},{"month":9,"riseRate":0.5,"avgChangeRate":0.005555},{"month":10,"riseRate":0.75,"avgChangeRate":0.065387},{"month":11,"riseRate":0.25,"avgChangeRate":-0.033954},{"month":12,"riseRate":1,"avgChangeRate":0.075845}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}